BA

The Boeing Company

57
Fundamentals73/ 100
Valuation50/ 100
Upside potential57/ 100
Risk potential20/ 100

BA has the edge over ESAB overall, supported by stronger fundamentals and stronger valuation.

ESAB

ESAB Corporation

43
Fundamentals45/ 100
Valuation30/ 100
Upside potential40/ 100
Risk potential29/ 100

ESAB's outlook is improving, though it still trails on the overall score.

BA Fundamentals

MetricStatus
Stable
Healthy
Stable
Under pressure

BA's profitability is currently healthy, and its revenue and cash flow are stable, but its balance sheet is under pressure.

ESAB Fundamentals

MetricStatus
Healthy
Stable
Stable
Weak

ESAB's revenue is currently healthy, and its profitability and cash flow are stable, but its balance sheet is weak.

BA PE Valuation

CHEAPFAIREXPENSIVE25x51x76x102x
CHEAPFAIREXPENSIVE25x51x76x102x
LevelPEPriceVs current
Current18x$172—
Cheap51x$496+189%
Fair82x$790+360%
Expensive91x$876+411%

Historical ranges are pointers, not guarantees.

BA has the edge over ESAB in the historical PE scenario, which offers more potential upside but is not a forecast.

ESAB PE Valuation

CHEAPFAIREXPENSIVE9.1x18x27x36x
CHEAPFAIREXPENSIVE9.1x18x27x36x
LevelPEPriceVs current
Forward14x$82.55—
Cheap18x$43.61-47%
Fair26x$63.73-23%
Expensive29x$71.57-13%
Current34x$82.55—

Historical ranges are pointers, not guarantees.

ESAB's PE is in its expensive range at 34x. If earnings grow as analysts expect, today's price would be 14x next year's earnings, in its cheap range.

BA Forward outlook

MetricOutlook
--
Returning to profit
Growth
Improving
Limited
Low

BA has the edge over ESAB on the outlook, with more favorable profitability expectations.

ESAB Forward outlook

MetricOutlook
Strongly improving
Growth
Growth
Stable
Limited
Moderate

Analysts expect earnings and revenue growth for ESAB, with profitability holding steady.

BA Risk to reward

ScenarioChangePrice
Upside+26%$216.09
Downside-20%$137.47

Calculated from the latest close: $171.55 on Nov 12.

BA has a better modeled risk to reward balance than ESAB, with more potential upside and less potential downside.

ESAB Risk to reward

ScenarioChangePrice
Upside+19%$98.33
Downside-29%$58.89

Calculated from the latest close: $82.55 on Nov 12.

ESAB trails BA on modeled risk to reward, with less potential upside and more potential downside.

BA Earnings Per Share

Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
Q4 2023: $-3.67Q1 2024: $-3.54Q2 2024: $-5.62Q3 2024: $-12.89Q4 2024: $-18.36Q1 2025: $-17.96Q2 2025: $-16.55Q3 2025: $-13.72Q4 2025: $2.48Q1 2026: $2.53Q2 2026: $2.78Q3 2026: $9.66
QuarterTTM EPSYoY
Q3 2026$9.66+$23.38
Q2 2026$2.78+$19.33
Q1 2026$2.53+$20.49
Q4 2025$2.48+$20.84
Q3 2025-$13.72-$0.83
Q2 2025-$16.55-$10.93
Q1 2025-$17.96-$14.42
Q4 2024-$18.36-$14.69

BA has the edge over ESAB on earnings, with more consistent year-over-year improvement.

ESAB Earnings Per Share

Q4 2023: $3.36Q1 2024: $3.82Q2 2024: $4.10Q3 2024: $4.27Q4 2024: $4.31Q2 2025: $4.43Q3 2025: $4.17Q4 2025: $3.96Q4 2025: $3.67Q2 2026: $3.35Q3 2026: $2.76Q4 2026: $2.44Forward: $5.91
Q4 2023: $3.36Q1 2024: $3.82Q2 2024: $4.10Q3 2024: $4.27Q4 2024: $4.31Q2 2025: $4.43Q3 2025: $4.17Q4 2025: $3.96Q4 2025: $3.67Q2 2026: $3.35Q3 2026: $2.76Q4 2026: $2.44Forward: $5.91
QuarterTTM EPSYoY
Forward$5.91+142%
Q3 2026$2.44-38%
Q2 2026$2.76-34%
Q1 2026$3.35-24%
Q4 2025$3.67-15%
Q3 2025$3.96-7.3%
Q2 2025$4.17+1.7%
Q1 2025$4.43+16%
Q4 2024$4.31+28%

ESAB's earnings per share have fallen from their peak: $2.44 over the past year, against $4.43 in early 2025.

BA Quarterly Revenue

Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
Q4 2023: $22BQ1 2024: $16.6BQ2 2024: $16.9BQ3 2024: $17.8BQ4 2024: $15.2BQ1 2025: $19.5BQ2 2025: $22.7BQ3 2025: $23.3BQ4 2025: $23.9BQ1 2026: $22.2BQ2 2026: $24.6BQ3 2026: $24.2B
QuarterRevenueYoY
Q3 2026$24.2B+3.9%
Q2 2026$24.6B+8%
Q1 2026$22.2B+14%
Q4 2025$23.9B+57%
Q3 2025$23.3B+30%
Q2 2025$22.7B+35%
Q1 2025$19.5B+18%
Q4 2024$15.2B-31%

BA has the edge over ESAB on sales, with more consistent year-over-year improvement.

ESAB Quarterly Revenue

Q4 2023: $689MQ1 2024: $690MQ2 2024: $707MQ3 2024: $673MQ4 2024: $671MQ2 2025: $678MQ3 2025: $716MQ4 2025: $728MQ4 2025: $721MQ2 2026: $746MQ3 2026: $808MQ4 2026: $825M
Q4 2023: $689MQ1 2024: $690MQ2 2024: $707MQ3 2024: $673MQ4 2024: $671MQ2 2025: $678MQ3 2025: $716MQ4 2025: $728MQ4 2025: $721MQ2 2026: $746MQ3 2026: $808MQ4 2026: $825M
QuarterRevenueYoY
Q3 2026$824.5M+13%
Q2 2026$807.6M+13%
Q1 2026$745.6M+9.9%
Q4 2025$721M+7.5%
Q3 2025$727.8M+8.1%
Q2 2025$715.6M+1.2%
Q1 2025$678.1M-1.7%
Q4 2024$670.8M-2.7%

ESAB's revenue has grown year over year for six quarters in a row: $825M last quarter, up 13% from the same quarter a year ago.

BA Free Cash Flow

Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
Q4 2023: $3BQ1 2024: −$3.9BQ2 2024: −$4.3BQ3 2024: −$2BQ4 2024: −$4.1BQ1 2025: −$2.3BQ2 2025: −$200MQ3 2025: $238MQ4 2025: $375MQ1 2026: −$1.5BQ2 2026: $631MQ3 2026: $464M
QuarterFree cash flowYoY
Q3 2026$464M+95%
Q2 2026$631M+$831M
Q1 2026-$1.5B+$836M
Q4 2025$375M+$4.5B
Q3 2025$238M+$2.2B
Q2 2025-$200M+$4.1B
Q1 2025-$2.3B+$1.6B
Q4 2024-$4.1B-239%

BA has the edge over ESAB on cash flow, with more consistent year-over-year improvement.

ESAB Free Cash Flow

Q4 2023: $103MQ1 2024: $37MQ2 2024: $74MQ3 2024: $90MQ4 2024: $102MQ2 2025: $28MQ3 2025: $37MQ4 2025: $70MQ4 2025: $77MQ2 2026: $33MQ3 2026: $16MQ4 2026: $54M
Q4 2023: $103MQ1 2024: $37MQ2 2024: $74MQ3 2024: $90MQ4 2024: $102MQ2 2025: $28MQ3 2025: $37MQ4 2025: $70MQ4 2025: $77MQ2 2026: $33MQ3 2026: $16MQ4 2026: $54M
QuarterFree cash flowYoY
Q3 2026$54.4M-23%
Q2 2026$15.7M-58%
Q1 2026$33.2M+18%
Q4 2025$77.4M-24%
Q3 2025$70.3M-22%
Q2 2025$37.4M-49%
Q1 2025$28.1M-24%
Q4 2024$102.2M-0.9%

ESAB's free cash flow has been positive every quarter since early 2021: $181M over the past year, down 24% from the year before.

BA Total Shares

Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
Q4 2023: 606MQ1 2024: 613MQ2 2024: 616MQ3 2024: 619MQ4 2024: 647MQ1 2025: 753MQ2 2025: 757MQ3 2025: 760MQ4 2025: 762MQ1 2026: 788MQ2 2026: 791MQ3 2026: 793M
PeriodChange %Net change
Quarterly+0.3%+2.1M shares
1 year+4.3%+32.8M shares
3 years+31%+186M shares
5 years+35%+204M shares
Available history+40%+227M shares

BA has 793M diluted shares, up 4.3% from a year ago.

ESAB Total Shares

Q4 2023: 61MQ1 2024: 61MQ2 2024: 61MQ3 2024: 61MQ4 2024: 61MQ2 2025: 61MQ3 2025: 61MQ4 2025: 61MQ4 2025: 61MQ2 2026: 61MQ3 2026: 62MQ4 2026: 62M
Q4 2023: 61MQ1 2024: 61MQ2 2024: 61MQ3 2024: 61MQ4 2024: 61MQ2 2025: 61MQ3 2025: 61MQ4 2025: 61MQ4 2025: 61MQ2 2026: 61MQ3 2026: 62MQ4 2026: 62M
PeriodChange %Net change
Quarterly+1.2%+763K shares
1 year+1.9%+1.2M shares
3 years+2.7%+1.7M shares
5 years+4%+2.4M shares

ESAB has the edge over BA on shareholder dilution, with a more favorable share count trend.

BA Net Leverage

Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
Q4 2023: 36.4xQ1 2024: 36.1xQ2 2024: 361.8xQ4 2025: 6.9xQ1 2026: 6.0xQ2 2026: 5.7xQ3 2026: 3.0x
QuarterNet LeverageStatus
Q3 20263.0xElevated
Q2 20265.7xHigh
Q1 20266.0xHigh
Q4 20256.9xHigh
Q2 2024361.8xHigh
Q1 202436.1xHigh
Q4 202336.4xHigh
Q3 202396.1xHigh

BA has the edge over ESAB on leverage, with a lower net debt burden relative to earnings.

ESAB Net Leverage

Q4 2023: 1.9xQ1 2024: 1.9xQ2 2024: 1.7xQ3 2024: 1.6xQ4 2024: 1.6xQ2 2025: 1.5xQ3 2025: 1.6xQ4 2025: 2.2xQ4 2025: 2.1xQ2 2026: 2.1xQ3 2026: 4.7xQ4 2026: 4.6x
Q4 2023: 1.9xQ1 2024: 1.9xQ2 2024: 1.7xQ3 2024: 1.6xQ4 2024: 1.6xQ2 2025: 1.5xQ3 2025: 1.6xQ4 2025: 2.2xQ4 2025: 2.1xQ2 2026: 2.1xQ3 2026: 4.7xQ4 2026: 4.6x
QuarterNet LeverageStatus
Q3 20264.6xHigh
Q2 20264.7xHigh
Q1 20262.1xModerate
Q4 20252.1xModerate
Q3 20252.2xModerate
Q2 20251.6xHealthy
Q1 20251.5xHealthy
Q4 20241.6xHealthy

ESAB's net debt is about 4.6 years of its operating earnings (EBITDA), up from 2.2 years a year ago.

BA Weekly Momentum

MetricValueStatus
RSI31.1Neutral
Stochastic9.6Oversold

BA's weekly RSI is 31 (neutral) and its Stochastic is 10 (oversold).

ESAB Weekly Momentum

MetricValueStatus
RSI50.3Neutral
Stochastic47.4Neutral

ESAB's weekly RSI is 50 (neutral) and its Stochastic is 47 (neutral).

BA PE vs Industrials Sector

MetricBASector medianRelative
PE18x24x26% below
PE %05858 pts below

BA has the edge over ESAB on valuation relative to its sector.

ESAB PE vs Industrials Sector

MetricESABSector medianRelative
PE34x24x41% above
PE %976829 pts above

ESAB is trading at 34x earnings, a 41% premium to the Industrials sector's median of 24x.

BA Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$184.67.1% below
20 week MA$203.816% below
50 week MA$215.520% below
100 week MA$205.917% below
200 week MA$200.614% below

BA is in a downtrend: it's below all five of its weekly moving averages, and 14% below its 200-week average.

ESAB Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$72.015% above
20 week MA$78.25.6% above
50 week MA$96.014% below
100 week MA$107.823% below
200 week MA$96.514% below

ESAB has the edge over BA on trend strength, trading above more of its moving averages.

BA Yearly ROI

YearStart priceEnd priceROI
2020$330.1$217.2-34%
2021$217.2$204.2-6%
2022$204.2$189.1-7.4%
2023$189.1$260.7+38%
2024$260.7$180.7-31%
2025$180.7$216.4+20%
2026 YTD$216.4$171.6-21%

BA has the edge over ESAB on returns for 2026, with the stronger performance.

ESAB Yearly ROI

YearStart priceEnd priceROI
2022$50.0$49.1-1.8%
2023$49.1$86.6+76%
2024$86.6$121.4+40%
2025$121.4$114.2-5.9%
2026 YTD$114.2$82.6-28%

ESAB has finished lower in two of the last four years. It's down 28% so far in 2026.

Give your agent the market.

Get API key